Skip to main content
Clinical Trials/ACTRN12621001233819
ACTRN12621001233819
Completed
未知

Efficacy and safety of deep brain stimulation to thalamic centromedian nucleus in Lennox-Gastaut syndrome (ESTEL): a randomised, double-blind, placebo-controlled epilepsy treatment trial

Associate Professor John ARCHER0 sites20 target enrollmentSeptember 13, 2021

Overview

Phase
未知
Intervention
Not specified
Conditions
ennox-Gastaut Syndrome
Sponsor
Associate Professor John ARCHER
Enrollment
20
Status
Completed
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
September 13, 2021
End Date
August 1, 2020
Last Updated
4 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Associate Professor John ARCHER

Eligibility Criteria

Inclusion Criteria

  • i) an electroclinical diagnosis of LGS; ii) generalised paroxysmal fast activity (GPFA) and slow spike\-and\-wave (SSW) on interictal EEG; and iii) generalised tonic seizures documented on prior video\-EEG monitoring or clearly described by a reliable eyewitness

Exclusion Criteria

  • i) participants with elevated risks for bleeding; ii) cerebral anatomical variations precluding safe CM\-DBS implantation; iii) predominant seizure type being focal impaired awareness seizures; iv) current or prior psychogenic non\-epileptic seizures

Outcomes

Primary Outcomes

Not specified

Similar Trials